Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kamel S Ahmed, Shenhuan Liu, Jing Mao, Jie Zhang & Lipeng Qiu. (2021) Dual-Functional Peptide Driven Liposome Codelivery System for Efficient Treatment of Doxorubicin-Resistant Breast Cancer. Drug Design, Development and Therapy 15, pages 3223-3239.
Read now
Read now
Kamel S. Ahmed, Sun Changling, Xiaotian Shan, Jing Mao, Lipeng Qiu & Jinghua Chen. (2020) Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. Journal of Liposome Research 30:3, pages 285-296.
Read now
Read now
Articles from other publishers (16)
Noriko Yokoyama, Hitoshi Nakayama & Kazuhisa Iwabuchi. (2023) Novel Insights into the Role of Kras in Myeloid Differentiation: Engaging with Wnt/β-Catenin Signaling. Cells 12:2, pages 322.
Crossref
Crossref
Partho Adhikary, M. A. Parvez Mahmud, Tahsin Solaiman & Zhong Lin Wang. (2022) Recent advances on biomechanical motion-driven triboelectric nanogenerators for drug delivery. Nano Today 45, pages 101513.
Crossref
Crossref
Shalini Mani, Geeta Swargiary & Stephen J. Ralph. (2022) Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy. Mitochondrion 62, pages 50-73.
Crossref
Crossref
Qiying Yao, Li Zhang, Yuchuan Wang, Junli Liu, Liu Yang & Yingjie Wang. (2021) LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613. Bioscience Reports 41:6.
Crossref
Crossref
Yongsheng Ruan, Hye Na Kim, Heather Ogana & Yong-Mi Kim. (2020) Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment. International Journal of Molecular Sciences 21:17, pages 6247.
Crossref
Crossref
Liuli Xv, Xinxin Qian, Yan Wang, Chenghuan Yu, Dingkui Qin, Yahui Zhang, Peng Jin & Qizhen Du. (2020) Structural Modification of Nanomicelles through Phosphatidylcholine: The Enhanced Drug-Loading Capacity and Anticancer Activity of Celecoxib-Casein Nanoparticles for the Intravenous Delivery of Celecoxib. Nanomaterials 10:3, pages 451.
Crossref
Crossref
Zhongxin Feng & Qi Chen. (2020) Raised CD40L expression attenuates drug resistance in Adriamycin‑resistant THP‑1 cells. Experimental and Therapeutic Medicine.
Crossref
Crossref
Alicja M. Gruszka, Debora Valli & Myriam Alcalay. (2019) Wnt Signalling in Acute Myeloid Leukaemia. Cells 8:11, pages 1403.
Crossref
Crossref
Melike Üner, Gülgün Yener & Mine Ergüven. (2019) Design of colloidal drug carriers of celecoxib for use in treatment of breast cancer and leukemia. Materials Science and Engineering: C 103, pages 109874.
Crossref
Crossref
Chaochao Zhao, Hongqing Feng, Lijun Zhang, Zhe Li, Yang Zou, Puchuan Tan, Han Ouyang, Dongjie Jiang, Min Yu, Chan Wang, Hu Li, Lingling Xu, Wei Wei & Zhou Li. (2019) Highly Efficient In Vivo Cancer Therapy by an Implantable Magnet Triboelectric Nanogenerator. Advanced Functional Materials 29:41, pages 1808640.
Crossref
Crossref
Kamel S. Ahmed, Xiaotian Shan, Jing Mao, Lipeng Qiu & Jinghua Chen. (2019) Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect. Materials Science and Engineering: C 99, pages 1448-1458.
Crossref
Crossref
Kathrin Renner, Anton Seilbeck, Nathalie Kauer, Ines Ugele, Peter J. Siska, Christina Brummer, Christina Bruss, Sonja-Maria Decking, Matthias Fante, Astrid Schmidt, Kathrin Hammon, Katrin Singer, Sebastian Klobuch, Simone Thomas, Eva Gottfried, Katrin Peter & Marina Kreutz. (2018) Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Frontiers in Pharmacology 9.
Crossref
Crossref
Rhys Pritchard, Sara Rodríguez-Enríquez, Silvia Cecilia Pacheco-Velázquez, Vuk Bortnik, Rafael Moreno-Sánchez & Stephen Ralph. (2018) Celecoxib inhibits mitochondrial O2 consumption, promoting ROS dependent death of murine and human metastatic cancer cells via the apoptotic signalling pathway. Biochemical Pharmacology 154, pages 318-334.
Crossref
Crossref
Ying Lu, Ling-Ling Liu, Shou-Sheng Liu, Zhi-Gang Fang, Yong Zou, Xu-Bin Deng, Zi-Jie Long, Quentin Liu & Dong-Jun Lin. (2016) Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells. Journal of Translational Medicine 14:1.
Crossref
Crossref
Ying Lu, Xiang-Fu Liu, Ting-Rong Liu, Rui-Fang Fan, Yi-Chuan Xu, Xiang-Zhong Zhang & Ling-Ling Liu. (2016) Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function. Biomedicine & Pharmacotherapy 84, pages 1551-1557.
Crossref
Crossref
XIANYING MENG, QIANG ZHANG, GUIBIN ZHENG, RENZHU PANG, TEBO HUA, SHUAI YANG & JIE LI. (2014) Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice. Oncology Letters 7:6, pages 2053-2058.
Crossref
Crossref